Form 4 for ADPT Adaptive Biotechnologies Corp
Accepted 2024-10-10 00:00:00 ET · period of report 2024-10-08 · accession 0001062993-24-017564 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-10-10 | 2024-10-08 | ADPT | BOBULSKY SUSAN | Chief Commercial Off, MRD | M - OptEx | $1.98 | +5,000 | 253.3K | +2% | +$9,900 |
| D | 2024-10-10 | 2024-10-08 | ADPT | BOBULSKY SUSAN | Chief Commercial Off, MRD | M - OptEx | $0.00 | -5,000 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-10-08 | M | A | 5,000 | $1.98 | 253,290 | D | — | — | |
| 2 | Derivative | Stock Option (right to buy) | 2024-10-08 | M | D | 5,000 | $0.00 | 0 | D | $1.98 · — to 2024-10-13 | 5,000 Common Stock | (F1) The options are fully exercisable. |